Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombocytopenia
•
Hematology
•
Benign Hematology
•
ITP
Patient with known ITP, now having a relapse in the setting of a mitral valve vegetation and responding to steroids and IVIG, would you consider a TPO agonist and wean steroids?
Would steroid use be a sepsis risk?
Related Questions
How would you treat a young woman with refractory ITP surrounding pregnancy who responds to fostamatinib?
Is there a correlation between spleen size and degree of thrombocytopenia?
Do you prefer avatrombopag over eltrombopag in ITP?
What are your options for refractory ITP after steroids and TPO for elderly patients?
In a patient with a history of HIT, how would you reintroduce Heparin?
How do you approach the management of PFO in a young person with a cryptogenic CVA?
In extremely obese patients with spontaneous DVT/PE who have been anticoagulated for > 6 months, do you feel comfortable reducing the DOAC to prophylactic dose or do you prefer continuing full dose indefinite anticoagulation?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
How would you approach a patient with asymptomatic elevated PTT and positive lupus anticoagulant without history of thrombosis?
How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?